Dalpiciclib in HR+/HER2- ABC

Clinical trial NCT06301438 · RECRUITING

Trial details

NCT number: NCT06301438
Sponsor: RenJi Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Advanced Breast Cancer

Start date: 2024-05-03
Primary completion: 2027-01-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.